Results 131 to 140 of about 6,425 (142)

Soluble suppression of tumorigenicity 2 (sST2) for predicting disease severity or mortality outcomes in cardiovascular diseases: A systematic review and -analysis

IJC Heart and Vasculature, 2021
Keith Sai Kit Leung, Leonardo Roever
exaly  

Plasma soluble suppression of tumorigenicity 2 and depression after acute ischemic stroke

European Journal of Neurology, 2021
Yonghong Zhang, Sifan Qian, Aili Wang
exaly  

Soluble form of suppression of tumorigenicity-2 predicts clinical stability of inpatients with community-acquired pneumonia

Experimental Biology and Medicine, 2021
Shixue Sun, Baoqing Sun, Xiaohua Douglas Zhang   +2 more
exaly  

People also looked at

Frontiers in Cardiovascular Medicine, 2022
Li Feng, Yong Yuan
exaly  

Top bar navigation

Frontiers in Cardiovascular Medicine
Jianpeng Du
exaly   +2 more sources

Metabolic Complications Precede Alloreactivity and Are Characterized by Changes in Suppression of Tumorigenicity 2 Signaling

Biology of Blood and Marrow Transplantation, 2017
Sophie Paczesny, Adetola Kassim, Wichai Chinratanalab   +2 more
exaly  

Plasma Concentrations of Soluble Suppression of Tumorigenicity-2 and Interleukin-6 Are Predictive of Successful Liberation From Mechanical Ventilation in Patients With the Acute Respiratory Distress Syndrome*

Critical Care Medicine, 2016
R Scott Harris, James Januzzi, Jehan Alladina   +2 more
exaly  

Distribution of soluble suppression of tumorigenicity 2 (sST2), N-terminal pro-brain natriuretic peptide (NT-proBNP), high sensitive troponin I and high-sensitive troponin T in umbilical cord blood

Clinical Chemistry and Laboratory Medicine, 2016
Mina Lee, Hanah Kim, Mina Hur
exaly  

Prognostic and Diagnostic Value of Plasma Soluble Suppression of Tumorigenicity-2 Concentrations in Acute Respiratory Distress Syndrome

Critical Care Medicine, 2013
R Scott Harris, James Januzzi
exaly  

Electrosynthesis of molybdenum carbide-doped epitope-imprinted conductive polymers for the determination of soluble suppression of tumorigenicity 2 with a field effect transistor platform

Biosensors and Bioelectronics
David Jui-Yang Feng, James Thomas, Hung-Yin Lin   +2 more
exaly